 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
1ybg
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase/transferase inhibitor
|
 |
|
Title:
|
 |
Mura inhibited by a derivative of 5-sulfonoxy-anthranilic ac
|
|
Structure:
|
 |
Udp-n-acetylglucosamine 1-carboxyvinyltransferase chain: a, b, c, d. Synonym: enoylpyruvate transferase, udp-n-acetylglucosamine enolpyruvyl transferase, ept. Engineered: yes. Mutation: yes
|
|
Source:
|
 |
Enterobacter cloacae. Organism_taxid: 550. Gene: mura, murz. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
|
|
Biol. unit:
|
 |
Tetramer (from
)
|
|
Resolution:
|
 |
|
2.60Å
|
R-factor:
|
0.209
|
R-free:
|
0.253
|
|
|
Authors:
|
 |
S.Eschenburg,M.A.Priestman,F.A.Abdul-Latif,C.Delachaume,F.Fa E.Schonbrunn
|
Key ref:
|
 |
S.Eschenburg
et al.
(2005).
A novel inhibitor that suspends the induced fit mechanism of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA).
J Biol Chem,
280,
14070-14075.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
20-Dec-04
|
Release date:
|
15-Feb-05
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P33038
(MURA_ENTCC) -
UDP-N-acetylglucosamine 1-carboxyvinyltransferase
|
|
|
|
Seq: Struc:
|
 |
 |
 |
419 a.a.
419 a.a.*
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.5.1.7
- UDP-N-acetylglucosamine 1-carboxyvinyltransferase.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
Peptidoglycan Biosynthesis (Part 1)
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Phosphoenolpyruvate + UDP-N-acetyl-D-glucosamine = phosphate + UDP-N- acetyl-3-O-(1-carboxyvinyl)-D-glucosamine
|
 |
 |
 |
 |
 |
Phosphoenolpyruvate
|
+
|
UDP-N-acetyl-D-glucosamine
|
=
|
phosphate
|
+
|
UDP-N- acetyl-3-O-(1-carboxyvinyl)-D-glucosamine
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
cytoplasm
|
1 term
|
 |
|
Biological process
|
cell cycle
|
6 terms
|
 |
|
Biochemical function
|
catalytic activity
|
4 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Biol Chem
280:14070-14075
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
A novel inhibitor that suspends the induced fit mechanism of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA).
|
|
S.Eschenburg,
M.A.Priestman,
F.A.Abdul-Latif,
C.Delachaume,
F.Fassy,
E.Schönbrunn.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
MurA (UDP-N-acetylglucosamine enolpyruvyl transferase, EC 2.5.1.7) catalyzes the
first committed step in the synthesis of the bacterial cell wall. It is the
target of the naturally occurring, broad-spectrum antibiotic fosfomycin.
Fosfomycin, an epoxide, is a relatively poor drug because an ever-increasing
number of bacteria have developed resistance to fosfomycin. Thus, there is a
critical need for the development of novel drugs that target MurA by a different
molecular mode of action. We have identified a new scaffold of potent MurA
inhibitors, derivatives of 5-sulfonoxy-anthranilic acid, using high-throughput
screening. T6361 and T6362 are competitive inhibitors of MurA with respect to
the first substrate, UDP-N-acetylglucosamine (UNAG), with a K(i) of 16 microM.
The crystal structure of the MurA.T6361 complex at 2.6 angstrom resolution,
together with fluorescence data, revealed that the inhibitor targets a loop,
Pro112 to Pro121, that is crucial for the structural changes of the enzyme
during catalysis. Thus, this new class of MurA inhibitors is not active
site-directed but instead obstructs the transition from the open (unliganded) to
the closed (UNAG-liganded) enzyme form. The results provide evidence for the
existence of a MurA.UNAG collision complex that may be specifically targeted by
small molecules different from ground-state analogs of the enzymatic reaction.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
FIG. 1. The reaction catalyzed by MurA.
|
 |
Figure 2.
FIG. 2. The structures of T6361 and T6362.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2005,
280,
14070-14075)
copyright 2005.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.Miller,
C.J.Dunsmore,
J.A.Leeds,
S.G.Patching,
M.Sachdeva,
K.L.Blake,
W.J.Stubbings,
K.J.Simmons,
P.J.Henderson,
J.De Los Angeles,
C.W.Fishwick,
and
I.Chopra
(2010).
Benzothioxalone derivatives as novel inhibitors of UDP-N-acetylglucosamine enolpyruvyl transferases (MurA and MurZ).
|
| |
J Antimicrob Chemother, 65,
2566-2573.
|
 |
|
|
|
|
 |
C.Paradis-Bleau,
A.Lloyd,
F.Sanschagrin,
H.Maaroufi,
T.Clarke,
A.Blewett,
C.Dowson,
D.I.Roper,
T.D.Bugg,
and
R.C.Levesque
(2009).
Pseudomonas aeruginosa MurE amide ligase: enzyme kinetics and peptide inhibitor.
|
| |
Biochem J, 421,
263-272.
|
 |
|
|
|
|
 |
S.Goh,
J.M.Boberek,
N.Nakashima,
J.Stach,
and
L.Good
(2009).
Concurrent growth rate and transcript analyses reveal essential gene stringency in Escherichia coli.
|
| |
PLoS One, 4,
e6061.
|
 |
|
|
|
|
 |
H.Barreteau,
A.Kovac,
A.Boniface,
M.Sova,
S.Gobec,
and
D.Blanot
(2008).
Cytoplasmic steps of peptidoglycan biosynthesis.
|
| |
FEMS Microbiol Rev, 32,
168-207.
|
 |
|
|
|
|
 |
A.M.Jørgensen,
L.Tagmose,
A.M.Jørgensen,
K.P.Bøgesø,
and
G.H.Peters
(2007).
Molecular Dynamics Simulations of Na(+)/Cl(-)-Dependent Neurotransmitter Transporters in a Membrane-Aqueous System.
|
| |
ChemMedChem, 2,
827-840.
|
 |
|
|
|
|
 |
T.S.Mansour,
C.E.Caufield,
B.Rasmussen,
R.Chopra,
G.Krishnamurthy,
K.M.Morris,
K.Svenson,
J.Bard,
C.Smeltzer,
S.Naughton,
S.Antane,
Y.Yang,
A.Severin,
D.Quagliato,
P.J.Petersen,
and
G.Singh
(2007).
Naphthyl Tetronic Acids as Multi-Target Inhibitors of Bacterial Peptidoglycan Biosynthesis.
|
| |
ChemMedChem, 2,
1414-1417.
|
 |
|
|
|
|
 |
C.D.Klein,
and
A.Bachelier
(2006).
Molecular modeling and bioinformatical analysis of the antibacterial target enzyme MurA from a drug design perspective.
|
| |
J Comput Aided Mol Des, 20,
621-628.
|
 |
|
|
|
|
 |
F.M.Wagenlehner,
and
K.G.Naber
(2006).
Treatment of bacterial urinary tract infections: presence and future.
|
| |
Eur Urol, 49,
235-244.
|
 |
|
|
|
|
 |
Y.Yang,
A.Severin,
R.Chopra,
G.Krishnamurthy,
G.Singh,
W.Hu,
D.Keeney,
K.Svenson,
P.J.Petersen,
P.Labthavikul,
D.M.Shlaes,
B.A.Rasmussen,
A.A.Failli,
J.S.Shumsky,
K.M.Kutterer,
A.Gilbert,
and
T.S.Mansour
(2006).
3,5-dioxopyrazolidines, novel inhibitors of UDP-N- acetylenolpyruvylglucosamine reductase (MurB) with activity against gram-positive bacteria.
|
| |
Antimicrob Agents Chemother, 50,
556-564.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
|